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Biliary stenting via endoscopic retrograde cholangiopancreatography has greatly improved the quality of patient care over the last 30 
years. Plastic stent occlusion limits the life span of such stents. Attempts to improve plastic stent patency duration have mostly failed. 
Metal stents (self-expandable metal stents [SEMSs]) have therefore replaced plastic stents, especially for malignant biliary strictures. 
SEMS are at least 10 times more expensive than plastic stents. In this focused review, we will discuss basic mechanisms of plastic 
stent occlusion, along with a systematic summary of previous efforts and related studies to improve stent patency and potential new 
techniques to overcome existing limitations. Clin Endosc  2016;49:139-146
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INTRODUCTION
One of the most remarkable achievements in the history of 
therapeutic pancreatobiliary endoscopy is the introduction 
of biliary stent placement to prevent obstruction during en-
doscopic retrograde cholangiopancreatography (ERCP). This 
has become established as a treatment to resolve obstructive 
jaundice by a non-surgical approach. As this technique allows 
the relief of preoperative acute biliary obstruction, it is useful 
for stabilizing patients before surgery and enhancing their 
quality of life by enabling internal drainage in those who are 
not eligible for surgery.1,2
The main disadvantage of plastic stents is their limited 
diameter. This is set by the working channel in the duode-
noscope, which prevents use of plastic stents with an outer 
diameter of more than 12 Fr.3 This is not a major problem for 
patients who only require temporary stent placement, but can 
be a major issue for patients who require long-term placement 
of a stent. Patients with early stent occlusion before scheduled 
replacement can experience sudden obstruction of bile flow 
and complain of symptoms of recurrent biliary obstruction. 
This can also lead to acute cholangitis and sepsis, which can 
be life-threatening. Frequent stent replacement also increases 
medical costs and reduces the quality of life of patients with 
general illness.
In this focused review, we will discuss mechanisms of plas-
tic stent occlusion, along with a summary of previous efforts 
and related studies to improve stent patency, and potential 
new techniques to overcome existing limitations.
MECHANISMS OF BILIARY STENT 
OCCLUSION
Biliary plastic stents were first introduced in 1979, and the 
mechanisms of biliary stent occlusion were thoroughly in-
vestigated 20 to 30 years ago.4 Early stent occlusion within 30 
days, although very rare, mostly occurred due to positioning 
error, blood clots, debris, or mucus from a mucin-producing 
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tumor.5 This review will focus on late stent occlusion (≥30 
days post-placement).
The widely-accepted theory is that bacterial biofilm and 
biliary sludge both play major roles, along with the extent of 
bacterial infection and duodenobiliary reflux of dietary fi-
ber.3,6-8 Biliary sludge is different from cholesterol-rich sludge, 
which is generally related to gallstone formation. The biliary 
sludge that causes stent occlusion is mainly composed of 
crystals of calcium bilirubinate and calcium palmitate formed 
by bacterial enzymes.6-12 It is also known that several types 
of proteins (such as fibronectin, vitronectin, laminin, fibrin, 
and collagen), which are derived from bacteria of unknown 
specific origin but are not naturally present in bile, form a 
conditioning film, making the bacteria more adhesive, and 
also work with the bacteria to produce biliary sludge.13-17 The 
formation of a biofilm that occurs as a result of attachment 
of these proteins onto the inner surface of a stent is known to 
play a major role in the initiation of sludge accumulation, but 
its exact role in the process of stent occlusion is still unknown. 
THE ROLE OF BACTERIAL 
COLONIZATION IN STENT OCCLUSION
The most important factor in the process of stent occlusion 
is bacterial colonization. Micro-organisms isolated from oc-
cluded biliary stents include anaerobic bacterial species, fungi, 
and aerobic bacterial species. The gram-positive Enterococcus 
species, and gram-negative Escherichia coli and Klebsiella 
species are most commonly encountered among aerobic bac-
teria, with Clostridium species among anaerobic bacteria. The 
species identified vary greatly among reported series, possibly 
affected by sites where stents were implanted, time to test after 
removal, interval antibiotic use, and inadequate techniques to 
identify anaerobic species. In any case, the synergistic effect 
between bacterial adherence and biofilm formation caused by 
these bacteria is known to trigger stent obstruction. Studies 
have suggested that stent patency may vary depending on 
the types of bacteria or the types of byproducts and proteins 
released by different bacteria. Other studies on scanning elec-
tron microscopy (SEM) have suggested that biofilm thickness 
may vary depending on their combined action.18
SCANNING ELECTRON MICROSCOPY 
EXAMINATIONS
Biofilms generally do not become thick enough to cause 
complete stent occlusion. Removed biliary plastic stents eval-
uated by longitudinal sectioning show a less than 0.5-mm-
Fig. 1. (A-E) Retrieved biliary plastic stents with the inner layer exposed by longitudinal cutting. The dark greenish biofilms do not contribute significantly to increased 
thickness of the occluded inner layer. Stent occlusion is mostly caused by debris, sludge, and food components.
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thick inner layer of biofilm; the occlusion is mostly caused by 
debris, sludge, and food components (Fig. 1).
A SEM examination of stents revealed interesting facts in 
terms of the change in biofilm depending on the time they 
were retrieved. Fig. 2 shows the inner surface of a stent re-
trieved approximately 4 weeks after implantation. The biofilm 
starts to appear on the inner surface of the stent (Fig. 2A); the 
biofilm itself becomes gradually thicker relatively evenly, and 
the surface becomes more solid (Fig. 2B-D). Fig. 3 shows the 
inside of a stent retrieved approximately 8 weeks after implan-
tation. Sludge covers the biofilm, rapidly narrowing the inner 
diameter of the stent (Fig. 3A-C). It also appears that debris, 
presumably derived from causes other than sludge, is attached 
to the inner layer of the stent without the sludge (Fig. 3D).
What this suggests is that the biofilm is associated with 
the initiation of stent occlusion but that overall thickening of 
the biofilm is not the cause of total occlusion. It may be pos-
sible that a biofilm on the inner surface of a stent can make 
the surface irregular, facilitating the accumulation of sludge 
or debris. Various biological factors mentioned above and a 
number of physical factors (such as stent shapes, side holes, 
duodenobiliary reflux of different food components, inner 
coating status, bile composition status due to underlying dis-
ease, and preexisting cholelithiasis) are also thought to work 
together to promote sludge attachment to the inner layer. To 
date, antibiotics to inhibit the formation of biofilm have not 
improved stent patency.
METHODS FOR PREVENTION OF 
PLASTIC STENT OCCLUSION
Stent diameter
Stents with a larger diameter have longer patency because it 
takes longer for the inner cavity to fill with foreign substanc-
es.19 However, it is impossible to endlessly extend the diameter 
of the working channel of an endoscope due to its design, and 
thus the maximum outer diameter of a plastic stent is 11.5 Fr 
at most. Then 10-Fr plastic stents require a duodenoscope with 
an accessory channel of 3.7 mm, and 11.5-Fr plastic stents re-
quire a duodenoscope with an accessory channel of 4.2 mm.20 
However, prospective studies found no major difference in the 
outcome between 10- and 11.5-Fr stents, and the mean dura-
tion of stent patency was 3 to 6 months.3,21-23
Fig. 2. Scanning electron microscopy (SEM) examination of stent occlusion. SEM images of the inner surface of a stent retrieved at about 4 weeks. The biofilm starts 
to appear on the inner surface of the stent (A, ×250). The biofilm itself becomes gradually thicker relatively evenly (B, ×250; C, ×30). The surface becomes more solid 
and cracked in some areas (D, ×150).
A  B
C  D
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Studies evaluating thinner-walled stents with the same out-
er diameter, and the use of single versus multiple plastic stents 
are needed.
Stent composition and shape 
One can assume that the composition or shape of plastic 
stents might affect stent patency; however, previous studies 
have suggested that patency was not significantly affected 
by composition (Teflon, polyurethane, or polyethylene) or 
shape.24-27
Straight plastic stents are thought to have a longer patency 
than pigtail plastic stents because they are much less resistant 
to flow. However, compared to the inner diameter, which lim-
its the time to stent occlusion, the effect of stent shape does 
not seem as significant. Pigtail stents show lesser migration 
than straight stents because anchoring is well-maintained,20 
there is less likelihood of food clinging because they have 
multiple drain holes on the side, unlike the flap of the straight 
type, and there is less likelihood of decreasing bile flow veloc-
ity when a distal part touches the duodenal wall after partial 
migration (Fig. 4).
Scheduled stent exchange
Unexpected stent occlusion may lead to recurrent jaundice 
and cholangitis, or even sepsis without immediate treatment, 
which may be life-threatening. The best known preventive 
measure is replacing the stent before it becomes occluded.28
The median patency of 10-Fr plastic stents is 4 to 5 months 
in general, and the risk of stent occlusion increases significant-
ly after 3 months. Many centers recommend stent replace-
ment every 3 months on a scheduled (not as needed) basis.29,30 
However, this depends on underlying pathology, because stent 
occlusion is rare when death is imminent in patients with a 
malignant disease.6 Therefore, it seems wise to aggressively 
use this method in patients with benign diseases who require 
repeated stent replacement.31
Antibiotics with or without choleretics
As bacterial colonization was found to be the most import-
ant cause of biliary plastic stent occlusion, in vitro and in vivo 
studies have been conducted with various antibiotics; how-
ever, none were found to prolong stent patency.18 Attempts 
have been made to induce synergistic effects by combining 
antibiotics with choleretic agents such as ursodeoxycholic 
Fig. 3. Scanning electron microscopy (SEM) examination of stent occlusion. SEM images of the inner surface of a stent retrieved at about 8 weeks. Sludge covers 
the biofilm and narrows the inner diameter of the stent (A, ×30; B, ×150). The biofilm is exposed in some areas that are not covered by sludge (C, ×150). Debris, pre-
sumably derived from other causes even before the formation of the biofilm, is attached to the inner layer of the stent (D, ×100).
C  D
A  B
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acid or terpene. However, the Cochrane review including a 
meta-analysis of 5 randomized trials reported no significant 
effect on stent patency or mortality rate.32
Antibacterial coating or hydrophilic coating method
Similar to antibiotic administration, studies evaluating 
stents that incorporate antibiotics failed to show prolonged 
patency with in vitro or pilot studies.33-35 These unfavorable 
results may be associated with technical issues such as inabil-
ity to release antibiotics for a prolonged period of time, or 
because of bacterial resistance.6
In vitro experimental studies have demonstrated that Teflon 
stents with a low coefficient of friction or stents with a hydro-
philic coating can inhibit bacterial colonization and sludge 
formation.36,37 Because bacterial adhesion to plastic stents is 
associated with surface hydrophobicity, studies have started 
to explore hydrophilic coatings.38-41 Earlier studies reporting 
promising results had received much attention as a break-
through; however, subsequent prospective large-scale studies 
failed to show prolonged patency.42,43 The possible explana-
tions are as follows: (1) the coated surface could have been 
damaged by guide wire manipulation during stent placement 
or by duodenobiliary reflux, and (2) the hydrophilic coating 
could have been degraded over time even before the initiation 
of stent occlusion.
In vitro studies were conducted to explore silver coating 
in the same context, but a clinical study has not been report-
ed.44,45
Stent design: stent without side holes
Many straight plastic stents have side holes created on pur-
pose or added in the process of making the anti-migration 
flap. Coene and colleagues46 found that sludge accumulation 
was more frequent around side holes, and devised and stud-
ied a new stent without side holes. A known mechanism 
of increased encrustation of sludge around side holes is the 
creation of microturbulence, affecting the friction coefficient 
of bile flow.46,47 This observation stimulated other studies, but 
prolonged stent patency was not seen.24-26,48,49
Stent design: antireflux valve
The hypothesis that duodenobiliary reflux may induce bio-
film or sludge formation has led to the introduction of a plas-
tic stent with an antireflux valve. This plastic antireflux stent 
showed 1.5-times longer stent patency than the existing stan-
dard type.50 A follow-up study used a similar antireflux plastic 
Fig. 4. Factors causing plastic biliary stent malfunction. (A, B) Distal ends of the straight stents are touching the duodenal wall as a result of partial distal migration. 
This may lead to flow disturbance and sludge accumulation, causing occlusion. (C, D) The straight stents have not migrated, but dietary fibers are clinging to the side 
flaps, causing stent occlusion. (E, F) Distal ends of the pigtail stents are touching the duodenal wall or partially migrated, but the side holes still allow bile flow.
D                                                      E                                                  F
A  B  C
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stent.51 Larger, prospective follow-up studies are needed.
An antireflux valve was also investigated with self-expand-
able metal stents (SEMS) with the same idea, but studies failed 
to show improved results.52-54 This was possibly because (1) the 
valve was deformed by gastroduodenal secretion, or (2) the 
valve was compressed by the duodenal wall as a result of bow-
el motion or partial migration, causing valve malfunctioning 
and bile flow disturbance, as is also expected with antireflux 
plastic stents. 
Stent position
An animal study reported improved patency by placing a 
stent above the papilla, preventing bacterial colonization by 
food reflux from the intestine.55 This led to a prospective ran-
domized study in humans, but the results showed increased 
stent migration rather than improved patency.56 This was also 
investigated with SEMS with the same idea, but again stent 
migration increased without improving patency.57
CONCLUSIONS
Endoscopic biliary stenting has been extensively investi-
gated since the development of therapeutic endoscopy. For 
more than 30 years, however, no studies have produced any 
remarkable results to prolong stent patency, other than the 
implantation of larger-caliber stents or SEMS. As plastic bil-
iary stents are easy to insert and remove, and financially less 
of a burden than SEMS, plastic stents with improved function 
to reduce occlusion are awaited. In the future, we also hope 
to see more studies on the following: (1) the development of 
self-expandable plastic stents or bioabsorbable plastic stents, 
ensuring larger calibers; (2) the development of new types 
of plastic stents with combined benefits of both straight and 
pigtail types, to eliminate the effect of food components on 
the flap without affecting flow velocity; (3) the development 
of new materials effective for preventing biofilm formation 
as a special coating agent on the inner surface; or (4) if it is 
not possible to inhibit biofilm effectively, methods of coating 
the inner surface with substances that can prevent surface ir-
regularity caused by the biofilm itself, so that debris or sludge 
cannot be incorporated; (5) development of a larger-diameter 
channel ERCP scope; (6) testing of single versus multiple 
stents for routine malignant biliary obstruction (Table 1). 
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